228 related articles for article (PubMed ID: 33869218)
1. Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery.
Huang J; Feng Q; Wang L; Zhou B
Front Cell Dev Biol; 2021; 9():655161. PubMed ID: 33869218
[TBL] [Abstract][Full Text] [Related]
2. Modeling cancer progression using human pluripotent stem cell-derived cells and organoids.
Zhang M; Vandana JJ; Lacko L; Chen S
Stem Cell Res; 2020 Dec; 49():102063. PubMed ID: 33137568
[TBL] [Abstract][Full Text] [Related]
3. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
4. Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation.
Vandana JJ; Manrique C; Lacko LA; Chen S
Cell Stem Cell; 2023 May; 30(5):571-591. PubMed ID: 37146581
[TBL] [Abstract][Full Text] [Related]
5. Systems for the Functional Evaluation of Human Heart Tissues Derived from Pluripotent Stem Cells.
Murata K; Masumoto H
Stem Cells; 2022 Jun; 40(6):537-545. PubMed ID: 35303744
[TBL] [Abstract][Full Text] [Related]
6. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
[No Abstract] [Full Text] [Related]
7. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications.
Cotovio JP; Fernandes TG
Bioengineering (Basel); 2020 Apr; 7(2):. PubMed ID: 32283585
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling directs human pluripotent stem cells into vascularized cardiac organoids with chamber-like structures.
Liang PY; Chang Y; Jin G; Lian X; Bao X
Front Bioeng Biotechnol; 2022; 10():1059243. PubMed ID: 36466327
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Park M; Yoon YS
Korean Circ J; 2018 Nov; 48(11):974-988. PubMed ID: 30334384
[TBL] [Abstract][Full Text] [Related]
10. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
11. From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various Applications.
Moon SH; Bae D; Jung TH; Chung EB; Jeong YH; Park SJ; Chung HM
Int J Stem Cells; 2017 May; 10(1):1-11. PubMed ID: 28531912
[TBL] [Abstract][Full Text] [Related]
12. Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.
Sharma A; Sances S; Workman MJ; Svendsen CN
Cell Stem Cell; 2020 Mar; 26(3):309-329. PubMed ID: 32142662
[TBL] [Abstract][Full Text] [Related]
13. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
14. Biotechnological advances and applications of human pluripotent stem cell-derived heart models.
Muniyandi P; O'Hern C; Popa MA; Aguirre A
Front Bioeng Biotechnol; 2023; 11():1214431. PubMed ID: 37560538
[TBL] [Abstract][Full Text] [Related]
15. Insights Into Human Development and Disease From Human Pluripotent Stem Cell Derived Intestinal Organoids.
Daoud A; Múnera JO
Front Med (Lausanne); 2019; 6():297. PubMed ID: 31956653
[TBL] [Abstract][Full Text] [Related]
16. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
[TBL] [Abstract][Full Text] [Related]
17. Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges.
Gao Y; Pu J
Front Cell Dev Biol; 2021; 9():658088. PubMed ID: 34055788
[TBL] [Abstract][Full Text] [Related]
18. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
Tan SH; Ye L
J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
[TBL] [Abstract][Full Text] [Related]
19. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
20. Modeling and Targeting Alzheimer's Disease With Organoids.
Papaspyropoulos A; Tsolaki M; Foroglou N; Pantazaki AA
Front Pharmacol; 2020; 11():396. PubMed ID: 32300301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
